
Susan Prockop, MD, discusses an option available for the treatment of central nervous Epstein-Barr virus-positive posttransplant lymphoproliferative disease.<br />

Your AI-Trained Oncology Knowledge Connection!


Published: March 20th 2019 | Updated: